New EUCARE study explores post-acute outcomes after SARS-CoV-2 infection

We are pleased to share the publication of our new research article in the International Journal of Infectious Diseases: “Risk of post-acute symptoms and conditions after SARS-CoV-2 compared with other respiratory viral infections: a systematic review and meta-analysis.” The study compares the risk of persistent symptoms and health conditions following SARS-CoV-2 infection with those observed […]

VIROMARKERS consortium meets in Frascati | 10-11 September 2026

The VIROMARKERS consortium held a two-day project meeting, on Thursday 10 and Friday 11 September 2026, in the beatiful venue of Villa Tuscolana, Frascati, Italy. The meeting focused on reviewing progress across the project and discussing the main challenges and priorities for the months ahead. Alongside the plenary sessions, workshops and roundtables brought together partners […]

AREVIR 2026 – Joint EuCARE/VIROMARKERS Session

On 24-25 April, we gathered in Cologne, Germany for AREVIR 2026!The programme featured a dedicated EuCARE/VIROMARKERS session on 24 April, bringing together project partners for presentations and in-depth discussion within the broader meeting frameworkThese moments are key to keeping the consortium aligned beyond formal reporting lines, allowing perspectives to converge and ongoing work to be […]